Commonwealth Equity Services, LLC Biogen Inc. Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 28,343 shares of BIIB stock, worth $4.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

28,343

Previous 28,446 0.36%

Holding current value

$4.93 Million

Previous $6.6 Million 16.69%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$189.07 - $236.8 $19,474 - $24,390	-103 Reduced 0.36%	28,343 $5.49 Million
Q2 2024 Jul 31, 2024	BUY	$190.52 - $236.72 $1.19 Million - $1.48 Million	6,259 Added 28.21%	28,446 $6.6 Million
Q1 2024 Apr 29, 2024	SELL	$212.02 - $267.71 $90,108 - $113,776	-425 Reduced 1.88%	22,187 $4.78 Million
Q4 2023 Feb 06, 2024	SELL	$222.59 - $267.94 $178,962 - $215,423	-804 Reduced 3.43%	22,612 $5.85 Million
Q3 2023 Oct 23, 2023	BUY	$253.3 - $285.89 $109,678 - $123,790	433 Added 1.88%	23,416 $6.02 Million
Q2 2023 Aug 10, 2023	SELL	$275.25 - $318.06 $199,831 - $230,911	-726 Reduced 3.06%	22,983 $6.55 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $2.24 Million - $2.55 Million	-8,731 Reduced 26.91%	23,709 $6.59 Million
Q4 2022 Feb 07, 2023	BUY	$252.44 - $306.72 $2.37 Million - $2.88 Million	9,405 Added 40.83%	32,440 $8.98 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $62,495 - $86,175	-321 Reduced 1.37%	23,035 $6.15 Million
Q2 2022 Jul 19, 2022	SELL	$187.54 - $223.02 $307,753 - $365,975	-1,641 Reduced 6.56%	23,356 $4.76 Million
Q1 2022 May 04, 2022	BUY	$193.77 - $244.14 $178,268 - $224,608	920 Added 3.82%	24,997 $5.26 Million
Q4 2021 Jan 31, 2022	SELL	$223.92 - $287.77 $704,900 - $905,899	-3,148 Reduced 11.56%	24,077 $5.78 Million
Q3 2021 Oct 29, 2021	SELL	$282.99 - $369.05 $137,250 - $178,989	-485 Reduced 1.75%	27,225 $7.7 Million
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $1.46 Million - $2.33 Million	5,620 Added 25.44%	27,710 $9.6 Million
Q1 2021 May 04, 2021	SELL	$242.95 - $284.63 $243,678 - $285,483	-1,003 Reduced 4.34%	22,090 $6.18 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $513,865 - $773,495	-2,175 Reduced 8.61%	23,093 $5.65 Million
Q3 2020 Nov 05, 2020	SELL	$264.77 - $305.71 $478,704 - $552,723	-1,808 Reduced 6.68%	25,268 $7.17 Million
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $602,160 - $797,456	2,328 Added 9.41%	27,076 $7.24 Million
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $490,113 - $621,715	-1,823 Reduced 6.86%	24,748 $7.83 Million
Q4 2019 Feb 05, 2020	BUY	$220.06 - $304.07 $487,652 - $673,819	2,216 Added 9.1%	26,571 $7.88 Million
Q3 2019 Oct 30, 2019	SELL	$217.44 - $243.88 $365,081 - $409,474	-1,679 Reduced 6.45%	24,355 $5.67 Million
Q2 2019 Jul 19, 2019	SELL	$219.29 - $241.72 $856,327 - $943,916	-3,905 Reduced 13.04%	26,034 $6.09 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $591,401 - $925,021	2,729 Added 10.03%	29,939 $7.08 Million
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $304,957 - $386,261	-1,095 Reduced 3.87%	27,210 $8.19 Million
Q3 2018 Nov 06, 2018	BUY	$293.51 - $383.83 $82,769 - $108,240	282 Added 1.01%	28,305 $10 Million
Q2 2018 Jul 31, 2018	SELL	$257.52 - $306.91 $20,859 - $24,859	-81 Reduced 0.29%	28,023 $8.13 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $37,458 - $52,979	144 Added 0.52%	28,104 $7.7 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $8.6 Million - $9.63 Million	27,960	27,960 $8.91 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Biogen Inc. Transaction History